Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
MASLD and hypertension are at risk for fibrosis, and the coexistence of the two has a more significant impact on the risk of fibrosis.
Authors
- Bowen Qin (ORCID: https://orcid.org/0000-0003-0092-0766)
- Zhifeng Gao (ORCID: https://orcid.org/0000-0003-2984-8278)
- Jian Zhang (ORCID: https://orcid.org/0009-0006-3612-8120)
- Jiangwei Li (ORCID: https://orcid.org/0000-0002-4089-1747)
- Liang Bai (ORCID: https://orcid.org/0000-0003-3583-9888)
- Huan Deng (ORCID: https://orcid.org/0000-0002-1596-2013)
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-01-22
- DOI
- https://doi.org/10.3389/fmed.2025.1539283
- Citations
- 11
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 14.90